Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 2 | 2861 | 198 | 0.1675 | 0.1694 | 0.0692 | 0.0638 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1067 | 253 | 0.1789 | 0.1699 | 0.2371 | 0.2362 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 2 | 1140 | 287 | 0.1874 | 0.1699 | 0.2518 | 0.2362 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 837 | 184 | 0.1435 | 0.1699 | 0.2198 | 0.2362 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 3533 | 99 | 0.1739 | 0.1709 | 0.0280 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 3458 | 92 | 0.1704 | 0.1709 | 0.0266 | 0.0246 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 3389 | 65 | 0.1683 | 0.1709 | 0.0192 | 0.0246 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 1488 | 457 | 0.1710 | 0.1736 | 0.3071 | 0.3188 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 1562 | 528 | 0.1715 | 0.1736 | 0.3380 | 0.3188 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1562 | 486 | 0.1784 | 0.1736 | 0.3111 | 0.3188 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 3676 | 151 | 0.1689 | 0.1741 | 0.0411 | 0.0433 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3938 | 167 | 0.1807 | 0.1741 | 0.0424 | 0.0433 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3779 | 175 | 0.1727 | 0.1741 | 0.0463 | 0.0433 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 2 | 454 | 186 | 0.1651 | 0.1742 | 0.4097 | 0.4178 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 475 | 218 | 0.1583 | 0.1742 | 0.4589 | 0.4178 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 525 | 202 | 0.1990 | 0.1742 | 0.3848 | 0.4178 |
WM-115 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1178 | 671 | 0.1556 | 0.1743 | 0.5696 | 0.5669 |
WM-115 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1376 | 799 | 0.1770 | 0.1743 | 0.5807 | 0.5669 |
WM-115 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1379 | 759 | 0.1902 | 0.1743 | 0.5504 | 0.5669 |
COLO 858 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 1836 | 631 | 0.2041 | 0.1780 | 0.3437 | 0.3147 |
COLO 858 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1555 | 466 | 0.1845 | 0.1780 | 0.2997 | 0.3147 |
COLO 858 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1227 | 369 | 0.1453 | 0.1780 | 0.3007 | 0.3147 |
A-375 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 1 | 2938 | 245 | 0.1947 | 0.1801 | 0.0834 | 0.0950 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 453 | 159 | 0.1811 | 0.1801 | 0.3510 | 0.3728 |
A-375 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 2 | 2781 | 281 | 0.1807 | 0.1801 | 0.1010 | 0.0950 |